A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

Description

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.

Conditions

Coronary; Ischemic

Talk to us

Study Overview

On this page

Study Details

Study overview

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

Condition
Coronary; Ischemic
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Kettering

Kettering Health, Kettering, Ohio, United States, 45429

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Willing to provide informed consent
  • * Male or female, aged 40 and up (inclusive) at the time of enrollment
  • * Clinical suspicion of myocardial ischemia that clinician desired cardiac PET
  • * Completed cardiac PET within 2 weeks prior to study enrollment
  • * Patients unable to fit into CardioFlux device.
  • * Patients unable to lie supine for 5 minutes.
  • * Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable
  • * Ongoing atrial fibrillation or atrial flutter
  • * Life expectancy \<1 yrs. due to non-cardiovascular comorbidity

Ages Eligible for Study

40 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Genetesis Inc.,

Study Record Dates

2025-12-31